Drugs / CAR-NK
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06503497 | Jul 2024 → Jul 2025 overdue | pancreatic neoplasm | Zhejiang University | Recruiting | No outcome recorded |
| Phase 0 | NCT06478459 | Jun 2024 → Jun 2025 | malignant pancreatic neoplasm | Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-NK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06503497 ↗ |
| Modality | Cell therapy | “intratumoral NKG2D CAR-NK cell injection” NCT06478459 ↗ |
| Route | Other | “intratumoral CAR-NK injection” NCT06478459 ↗ |